Press release
Biobanking Market estimated to reach $68,084 million by 2023, growing at a CAGR of 4.6% | ASKION GmbH, CTI BIOTECH, Cureline, Inc., Excilone SARL, Firalis S.A., Hamilton Company, LabVantage Solutions
Biobank is a biorepository meant to collect and preserve biological materials that are used for diagnosis, biodiversity studies, and research. In addition, it is used to support the research of most common types of genetic disorders to develop personalized medicines and to maintain and update age demographic databases.The global biobanking market garnered $47,062 million in 2016, and is estimated to reach $68,084 million by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Rise in funding by private & government organizations for biobanking and increase in application areas of biobanked samples are the major factors that drive the growth of the global biobanking market. Moreover, upsurge in incidence of diseases such as cancer supports the market growth, owing to the fact that biobanked specimens are used in the treatment of several chronic diseases. However, ethical issues related to biobanking and lack of awareness about it are expected to impede the market growth. On the contrary, advancements in stem cell research and unmet medical needs in the emerging nations are anticipated to provide lucrative opportunity for the market expansion.
Top Companies Covered in this Report:
ASKION GmbH, CTI BIOTECH, Cureline, Inc., Excilone SARL, Firalis S.A., Hamilton Company, LabVantage Solutions, Inc., LGC Limited, PrecisionMed, Inc., ProMedDx LLC
Get sample copy of “Biobanking” at: https://www.premiummarketinsights.com/sample/AMR00013876
The global biobanking market is segmented by specimen type, type of biobank, ownership, application, and region. Based on specimen type, the market is categorized into blood products, solid tissue, cell lines, and others. On the basis of ownership, it is divided into national/regional agencies, nonprofit organization, university, and private. The applications covered in the study include therapeutic and research. Depending on type of biobank, the market is bifurcated into population and disease-oriented biobank. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS
This report provides an extensive analysis of the current and emerging trends and dynamics in the global biobanking market to identify the prevailing opportunities.
It presents a competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- and country-wise analyses are provided to understand the market trends and dynamics.
Have any query? Enquire about report at: https://www.premiummarketinsights.com/discount/AMR00013876
Fundamentals of Table of Content:
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biobanking Market Size
2.2 Biobanking Growth Trends by Regions
2.3 Industry Trends
3 Market Share by Key Players
3.1 Biobanking Market Size by Manufacturers
3.2 Biobanking Key Players Head office and Area Served
3.3 Key Players Biobanking Product/Solution/Service
3.4 Date of Enter into Biobanking Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Biobanking Sales by Product
4.2 Global Biobanking Revenue by Product
4.3 Biobanking Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Biobanking Breakdown Data by End User
Get Complete Report at: https://www.premiummarketinsights.com/buy/AMR00013876
Contact Us:
Call: +912067274191
Email: sales@premiummarketinsights.com
About Premiummarketinsights:
Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biobanking Market estimated to reach $68,084 million by 2023, growing at a CAGR of 4.6% | ASKION GmbH, CTI BIOTECH, Cureline, Inc., Excilone SARL, Firalis S.A., Hamilton Company, LabVantage Solutions here
News-ID: 1867763 • Views: …
More Releases from Premium Market Insights
The Future of HVAC: Trends and Innovations
The Europe HVAC System Market HVAC system market was valued at US$ 50,772.07 million in 2022 and is expected to reach US$ 1,25,024.86 million by 2030; it is estimated to grow at a CAGR of 11.9% from 2022 to 2030.
𝐆𝐫𝐚𝐛 𝐏𝐃𝐅 𝐓𝐨 𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞➜ https://www.businessmarketinsights.com/sample/BMIRE00026922?utm_source=OpenPR&utm_medium=10694
Rise in Demand for Energy-Efficient Solutions Fuel the Europe HVAC System Market
Greenhouse gases are the primary sources of global warming and climate change. These gases absorb…
Automated External Defibrillators Market New Business Opportunities and Investme …
The Automated External Defibrillators Market is estimated to reach US$ 2,207.94 million in 2030 from US$ 1,556.21 million by 2030; the market is projected to record a CAGR of 4.5% from 2022 to 2030.
Some of the key driving factors for the automated external defibrillators market growth are the increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. However, performance issues related to automated external…
Hydrolyzed Collagen Market Types and Applications, Industry Drivers, Future Dema …
The Hydrolyzed Collagen Market was valued at US$ 946.43 million in 2022 and is projected to reach US$ 1,322.60 million by 2028; it is expected to register a CAGR of 5.7% from 2022 to 2028.
Various end-use industries are adopting business expansion strategies and scaling production capacity to provide better customer satisfaction. For instance, in July 2020, Rousselot and Giusto Faravelli announced a distribution partnership in Italy, effective from October 2020.…
Aroma Ingredients Market Expectations & Growth, Trends Highlighted Until 2028
The Aroma Ingredients Market was valued at US$ 5376.90 million in 2021 and is projected to reach US$ 7692.62 million by 2028; it is expected to grow at a CAGR of 5.2% from 2021 to 2028.
Aroma ingredients are basically isolates of naturally sourced ingredients or chemically produced and are used as ingredients to add aromas or fragrance to various cosmetic and personal care products.
Based on product type, the global aroma…
More Releases for Biobanking
Global Biobanking Services & Biobanking Software Market Size, Share, Growth, Tre …
The Biobanking Services Market has witnessed substantial growth in recent years, driven by increasing investments in research and development activities across the healthcare and life sciences sectors. Biobanks play a crucial role in collecting, storing, and managing biological samples, such as blood, tissues, and cells, along with associated clinical and genetic data. This market's size is expected to expand significantly in the coming years due to rising demand for personalized…
Biobanking Market - Strength in Diversity, Defying Disease: Biobanking Fuelling …
Newark, New Castle, USA: The "Biobanking Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Biobanking Market: https://www.growthplusreports.com/report/biobanking-market/7617
This latest report researches the industry structure, sales, revenue, price and…
Mexico Biobanking Market Analysis to 2027
Biobanking Market: Overview
Transparency Market Research (TMR) has published a new report on the biobanking market for the forecast period of 2019-2027. According to the report, the global biobanking market was valued at ~US$ 2 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.
Biobanking Market: Overview
Growth of the global biobanking market is attributed to an increase in the demand for biobanks in genomics and biomedical research, and rising focus on precision medicine.
North America dominated the…
Biobanking Market Overview and Regional Outlook Study
Biobanking Market Introduction
The term 'biobanking' is often misused to refer to any collection of human biological specimens (biospecimens), regardless of the standards established for various tissue collection procedures or requirements pertaining to ethical and legal considerations. The process of collecting bodily fluids or tissue samples for usage in research to better understand health and disease is referred to as biobanking. Biobank is a sizable collection of biospecimens that are kept…
Biobanking Market: Rising Impressive Business Opportunities Analysis Forecast by …
(Latest Industry Report 2022) Biobanking Market report provides a basic overview of the industry including definitions and classifications. The market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The study provides a complex examination of the application, including a detailed cost assessment analysis of the products available in the global market with respect to the profit margins of established manufacturers.…
Biobanking Market Industry Trends, Estimation & Forecast, 2017 - 2025
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research. The major factors that drive the growth of the global biobanking market include a rise in funding support by private & government organizations.
Furthermore, increased incidence of chronic disease further propel the market growth. However, ethical and legal issues related to biobanking restrict market growth.
The major factors for the…